Comparison of aprepitant versus desloratadine for EGFR-TKI-induced pruritus: A randomized phase 2 clinical trial. Zhou T, Zhang Y, Ma Y, Ma W, et al. Cancer 2022;128:3969-3976.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhou T, Zhang Y, Ma Y, Ma W, et al. Comparison of aprepitant versus desloratadine for EGFR-TKI-induced pruritus: A randomized phase 2 clinical trial. Cancer 2022;128:3969-3976.
PMID: 36197287